prednisone and Autoimmune Diseases studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research Excerpts

Excerpt	Relevance	Reference
"The objective was to assess the efficacy of therapy with danazol in refractory immune thrombocytopenia associated with different rheumatic diseases."	9.08	Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases. ( Blanco, R; González-Gay, MA; Martinez-Taboada, VM; Rodriguez-Valverde, V; Sanchez-Andrade, A, 1997)
" Here we generated a single-cell transcriptional immune cell atlas based on prednisone-treated or untreated experimental autoimmune uveitis (EAU) mice."	8.02	Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease. ( Chen, B; Duan, R; Gao, Y; Li, H; Li, Z; Su, W; Wang, R; Wang, X; Xie, L; Zhu, L, 2021)
"To evaluate bone status in children born from mothers followed for autoimmune diseases and treated during pregnancy with low molecular weight heparin (LMVH) and/or prednisone."	7.80	Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. ( Bellisai, F; Brandi, ML; Cantarini, L; Cavalli, L; Cimaz, R; Frediani, B; Galeazzi, M; Iuliano, A; la Marca, G; Pagnini, I; Simonini, G, 2014)
"We report a case of a man with sarcoidosis and diffuse systemic sclerosis who showed improvement of both diseases after prednisone therapy and remains asymptomatic after three years of follow-up."	7.75	Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case. ( Borges da Costa, J; Marques Gomes, M; Mayer-da-Silva, A; Soares de Almeida, LM, 2009)
"As patients with B-cell lymphomas suffering from an underlying autoimmune condition undergoing therapy with the CD20 antibody rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) offer the unique possibility of monitoring effects of therapy on various rheumatologic parameters, we have evaluated serologic autoimmune markers and the clinical outcome of patients with autoimmune diseases (ADs) who received lymphoma treatment with R-CHOP during the course of their disease."	7.74	Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. ( Gaiger, A; Jaeger, U; Raderer, M; Schett, G; Skrabs, C; Troch, M; Wöhrer, S; Zielinski, CC; Zwerina, J, 2007)
"Thalidomide, an agent with antiangiogenic and immunomodulatory properties, is therapeutically effective in multiple myeloma, leprosy, and autoimmune diseases."	7.72	Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide. ( Fruehauf, S; Goldschmidt, H; Hartschuh, W; Ho, AD; Moehler, T; Neben, K; Witzens, M, 2004)
"Azathioprine, a thiopurine antimetabolite used in the treatment of immune-mediated thrombocytopenia in human beings and dogs, was used in 2 cases of immune-mediated thrombocytopenia in horses that failed to respond to corticosteroid therapy alone."	7.68	Azathioprine for treatment of immune-mediated thrombocytopenia in two horses. ( Beech, J; Cudd, TA; Gardner, SY; Humber, KA; Palmer, JE; Sommer, MM, 1991)
"The author presents evidence from published papers of research done by numerous investigators that Multiple, Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid."	7.67	Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988)
"The author presents evidence from published papers of research done by numerous investigators that Multiple Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid."	7.67	Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988)
"A 40-year-old woman with clinical and laboratory features of myasthenia gravis, hyperthyroidism, and polymyositis responded to treatment with prednisone alone."	7.66	Prednisone use in concurrent autoimmune diseases. ( Harati, Y; Patten, BM, 1979)
" Secondary and exploratory endpoints will include changes in disease activity scores over time, prednisone dose and biomarkers of inflammation and bone turnover."	5.34	Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial. ( Askanase, AD; Connolly-Strong, E; Furie, RA; Zhao, E; Zhu, J, 2020)
"Dermatomyositis is an autoimmune condition that results in significant morbidity and mortality through effects on muscle and skin."	5.33	Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis. ( Arbiser, JL; Nadiminti, U, 2005)
"Antenatal therapy with intravenous immunoglobulin (IVIG) and prednisone has been shown to improve fetal thrombocytopenia and reduce the incidence of intracranial hemorrhage in neonatal alloimmune thrombocytopenia."	5.12	Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. ( Berkowitz, RL; Bussel, JB; Kolb, EA; Lesser, M; McFarland, JG; Primani, A; Wissert, M, 2006)
"The objective was to assess the efficacy of therapy with danazol in refractory immune thrombocytopenia associated with different rheumatic diseases."	5.08	Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases. ( Blanco, R; González-Gay, MA; Martinez-Taboada, VM; Rodriguez-Valverde, V; Sanchez-Andrade, A, 1997)
"The 26-year-old patient with Graves disease and 10 weeks pregnant developed IAS after approximately 6 months treatment with methimazole."	4.95	Insulin autoimmune syndrome in a pregnant female: A rare case report. ( Hu, KX; Liu, JY; Tang, YL; Wang, J; Xu, J; Zeng, XX; Zhu, LY, 2017)
" Here we generated a single-cell transcriptional immune cell atlas based on prednisone-treated or untreated experimental autoimmune uveitis (EAU) mice."	4.02	Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease. ( Chen, B; Duan, R; Gao, Y; Li, H; Li, Z; Su, W; Wang, R; Wang, X; Xie, L; Zhu, L, 2021)
"The objective of this study was to compare efficacy of high versus low doses of prednisone for induction of remission in autoimmune pancreatitis (AIP)."	3.80	Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. ( Beuers, UH; Biermann, K; Brink, MA; Bruno, MJ; Buijs, J; de Buy Wenniger, LJ; Hansen, BE; Kuipers, EJ; Rauws, EA; van Buuren, HR; van Heerde, MJ; Verheij, J; Vleggaar, FP, 2014)
"The eighteen patients with focal autoimmune pancreatitis were treated with prednisone 0."	3.80	[Focal autoimmune pancreatitis versus pancreatic cancer: value of steroid treatment in the diagnosis]. ( Berger, Z, 2014)
"To evaluate bone status in children born from mothers followed for autoimmune diseases and treated during pregnancy with low molecular weight heparin (LMVH) and/or prednisone."	3.80	Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. ( Bellisai, F; Brandi, ML; Cantarini, L; Cavalli, L; Cimaz, R; Frediani, B; Galeazzi, M; Iuliano, A; la Marca, G; Pagnini, I; Simonini, G, 2014)
" Laboratory results were being consistent with disseminated intravascular coagulation secondary to protein S deficiency; treatment with fresh frozen plasma, intravenous immunoglobulins, and prednisone was started."	3.76	Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment. ( Alberio, L; Fluri, S; Kaczala, GW; Leibundgut, K, 2010)
"We report a case of a man with sarcoidosis and diffuse systemic sclerosis who showed improvement of both diseases after prednisone therapy and remains asymptomatic after three years of follow-up."	3.75	Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case. ( Borges da Costa, J; Marques Gomes, M; Mayer-da-Silva, A; Soares de Almeida, LM, 2009)
"As patients with B-cell lymphomas suffering from an underlying autoimmune condition undergoing therapy with the CD20 antibody rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) offer the unique possibility of monitoring effects of therapy on various rheumatologic parameters, we have evaluated serologic autoimmune markers and the clinical outcome of patients with autoimmune diseases (ADs) who received lymphoma treatment with R-CHOP during the course of their disease."	3.74	Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. ( Gaiger, A; Jaeger, U; Raderer, M; Schett, G; Skrabs, C; Troch, M; Wöhrer, S; Zielinski, CC; Zwerina, J, 2007)
"If our results are confirmed, mechanistic studies examining how prior use of insulin, prednisone, and, perhaps, gout medication might promote increased occurrence of multiple myeloma and how antilipid statins, estrogen replacement therapy, and certain medical conditions might protect against multiple myeloma may provide insights to the as yet unknown etiology of multiple myeloma."	3.73	Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. ( Baris, D; Inskip, P; Landgren, O; Zahm, SH; Zhang, Y; Zheng, T, 2006)
"Thalidomide, an agent with antiangiogenic and immunomodulatory properties, is therapeutically effective in multiple myeloma, leprosy, and autoimmune diseases."	3.72	Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide. ( Fruehauf, S; Goldschmidt, H; Hartschuh, W; Ho, AD; Moehler, T; Neben, K; Witzens, M, 2004)
" One patient with polymyalgia rheumatica who developed the inhibitor while receiving prednisone responded to single agent rituximab."	3.71	Rituximab in the treatment of acquired factor VIII inhibitors. ( Asch, AS; Cho, HJ; Michelis, MA; Peerschke, EI; Schechter, GP; Weksler, BB; Wiestner, A; Zeller, JA, 2002)
"Seven patients with this overlap syndrome (diagnosis based on the presence of serum hepatitis C antibody by RIBA and serum hepatitis C RNA by polymerase chain reaction, and serum hypergammaglobulinemia, elevated ANA or ASMA titers, or histological findings consistent with autoimmune hepatitis) were treated with prednisone with or without azathioprine or cyclosporine, and followed for a median duration of 44."	3.71	Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. ( Black, M; Bond, K; Hussain, H; Schiano, TD; Te, HS; Thomas, RM, 2001)
" Recently there have been 6 reported cases of successful treatment of blistering autoimmune diseases with MMF in combination with high dose prednisone therapy."	3.70	Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. ( Behrens, S; Grundmann-Kollmann, M; Kaskel, P; Kerscher, M; Korting, HC; Krähn, G; Leiter, U; Peter, RU, 1999)
"Serum bone Gla protein (BGP), carboxyterminal cross-linked telopeptide of type I collagen (ICTP) and aminoterminal propeptide of type III procollagen (PIIINP) levels were determined in 8 patients with autoimmune disorders (2 with systemic lupus erythematosus, 3 with rheumatoid arthritis, 2 with Sjögren's syndrome and 1 with mixed connective tissue disease) before and after 1, 2 and 4 months of treatment with oral prednisone (at a dosage of 1 mg/kg bw/day, p."	3.69	Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. ( Ambrosi, B; Conti, A; Ferrario, S; Ferrero, S; Sartorio, A, 1996)
"We present a case of pemoline-induced autoimmune hepatitis in a 46-yr-old woman who received the drug for management of her multiple sclerosis."	3.69	Pemoline-induced autoimmune hepatitis. ( Grace, ND; Kane, M; Sterling, MJ, 1996)
"Azathioprine, a thiopurine antimetabolite used in the treatment of immune-mediated thrombocytopenia in human beings and dogs, was used in 2 cases of immune-mediated thrombocytopenia in horses that failed to respond to corticosteroid therapy alone."	3.68	Azathioprine for treatment of immune-mediated thrombocytopenia in two horses. ( Beech, J; Cudd, TA; Gardner, SY; Humber, KA; Palmer, JE; Sommer, MM, 1991)
"The author presents evidence from published papers of research done by numerous investigators that Multiple, Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid."	3.67	Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988)
"The author presents evidence from published papers of research done by numerous investigators that Multiple Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid."	3.67	Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988)
" Despite preeclampsia our patient successfully completed her 6th pregnancy after treatment with corticosteroids, subcutaneous heparin, and low dose aspirin throughout the pregnancy."	3.67	Subclinical autoimmune disease and recurrent spontaneous abortion. ( Andreoli, J; Hakim, C; Maier, D; Parke, A; Randolph, J, 1986)
"A patient with autoimmune renal failure, cavitary lung lesions and arthritis experienced pancytopenia while prednisone therapy was being tapered."	3.66	Autoimmune pancytopenia. Lymphocyte inhibition of autologous but not allogenic bone marrow growth in vitro. ( Ascensao, JL; Banisadre, M; Bloom, PM; Roodman, GD; Zanjani, ED, 1980)
"A 40-year-old woman with clinical and laboratory features of myasthenia gravis, hyperthyroidism, and polymyositis responded to treatment with prednisone alone."	3.66	Prednisone use in concurrent autoimmune diseases. ( Harati, Y; Patten, BM, 1979)
"Childhood-onset systemic lupus erythematosus (cSLE) is an autoimmune disease that results in significant damage and often needs more aggressive treatment."	3.01	Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy. ( Guo, L; Liu, C; Liu, J; Pan, L; Punaro, M; Yang, S, 2023)
"To report the adverse effects associated with prolonged high-dose prednisone for the treatment of autoimmune inner ear disease (AIED)."	2.74	Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. ( Alexander, TH; Brookhouser, PE; Derebery, JM; Espeland, MA; Gantz, BJ; Gulya, AJ; Hammerschlag, PE; Hannley, M; Harris, JP; Hughes, GB; Moscicki, R; Nelson, RA; Niparko, JK; Rauch, SD; Telian, SA; Weisman, MH, 2009)
"The prednisone dose was reduced from 12."	2.74	Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? ( Cerquaglia, C; Curigliano, V; De Socio, G; Fonnesu, C; Gasbarrini, G; Giovinale, M; Granata, M; Manna, R; Massafra, U; Migliore, A; Soriano, A; Verrecchia, E, 2009)
"Seven patients (one with cold agglutinin disease, two with warm antibody autoimmune hemolytic anemia, four with chronic idiopathic thrombocytopenic purpura) previously refractory to conventional treatments were treated with weekly infusions of rituximab, 375 mg/m2, for 4 weeks."	2.70	B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. ( Baccarani, M; de Vita, S; Fanin, R; Iacona, I; Masolini, P; Patriarca, F; Prosdocimo, S; Regazzi, M; Russo, D; Sperotto, A; Zaja, F, 2002)
"One patient with atypical aplastic anemia showed partial recovery following lymphocyte depletion; the other five patients showed no evidence of a clinical response."	2.65	A trial of immunotherapy in aplastic anemia and pure red cell aplasia. ( Griffith, P; Klein, HG; Nienhuis, AW; Young, NS, 1983)
"The occurrence of acquired hemophilia A (AHA) is low and so the coexistence of EBA and AHA is extremely rare."	2.55	Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review. ( He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG, 2017)
"Manifestations include dacryoadenitis, sialadenitis, thyroiditis, pneumonitis, retroperitoneal fibrosis, pancreatitis, sclerosing cholangitis, tubulointerstitial nephritis, prostatitis, and hypophysitis."	2.47	IgG4-related systemic disease in a Native American man. ( Patel, SM; Szostek, JH, 2011)
"Steroids are useful in alleviating the symptoms of the acute presentation of autoimmune pancreatitis, but some questions remain open such as the dosage of steroids in the acute phase and the duration of steroid therapy; finally, it should be assessed if other immunosuppressive non-steroidal drugs may become the first-line therapy in patients with AIP without jaundice and without atrophic pancreas."	2.47	Therapeutic management and clinical outcome of autoimmune pancreatitis. ( Calculli, L; Cariani, G; Casadei, R; Corinaldesi, R; Morselli-Labate, AM; Pezzilli, R; Santini, D, 2011)
"Postpartum-acquired haemophilia A is a rare but potentially severe complication of pregnancy."	2.45	Postpartum-acquired haemophilia A: a description of three cases and literature review. ( Prejanò, S; Santoro, RC, 2009)
"Disease progression was significantly more frequent in patients presenting an immunological event or an M component."	2.41	Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. ( Arcache, J; Arnaud, P; Berger, F; Callet-Bauchu, E; Coiffier, B; Dumontet, C; Felman, P; Hequet, O; Salles, G; Thieblemont, C, 2002)
"The patient was diagnosed with autoimmune hepatitis and responded well to treatment with immunosuppressive drugs."	2.41	[Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus]. ( Belda Abad, G; Correa Estañ, JA; Hostalet Robles, F; Muñoz Bertrán, E; Muñoz Ramírez, E; Rosa Salazar, V, 2002)
"The association of ulcerative colitis (UC) and thrombotic thrombocytopenic purpura (TTP) is rare."	2.41	First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange. ( Baron, BW; Baron, JM; Cohen, R; Glunz, C; Hanauer, S; Hart, J; Jeon, HR; Peterson, A; Rubin, D, 2002)
"The diagnosis and management of autoimmune hepatitis continues to evolve as new diagnostic tests and new therapies are added to the armamentarium."	2.41	Autoimmune liver disease. Current standards, future directions. ( Gish, RG; Mason, A, 2001)
"Evans syndrome is a rare disorder characterized by combined autoimmune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA)."	2.41	Allogeneic stem cell transplantation for Evans syndrome. ( Burt, RK; Miranda, M; Oyama, Y; Papadopoulos, EB; Traynor, AE, 2001)
"Paraneoplastic pemphigus has been established as a newly recognized but distinctive syndrome."	2.40	Paraneoplastic pemphigus. ( Anhalt, GJ, 1997)
"Diagnosis of inflammatory dilated cardiomyopathy relies on the histological and immunohistological examination of endomyocardial biopsies."	2.40	[Therapy of dilated cardiomyopathies with and without inflammation]. ( Hufnagel, G; Maisch, B; Pankuweit, S, 1998)
"We report chronic lymphocytic leukemia-associated PNP in a patient who presented with extensive and debilitating painful oral ulcerations and received ablative therapy."	2.40	Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. ( Anhalt, GJ; Brodsky, RA; Grever, MR; Jones, RJ; Nousari, HC, 1999)
"Several subtypes of autoimmune chronic active hepatitis can be distinguished today, one variant of which seems to be associated with active hepatitis C virus infection."	2.39	[Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis]. ( Renner, EL, 1994)
"Insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE) are two common autoimmune disorders that affect women of childbearing age."	2.39	Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. ( Ferris, AM; Reece, EA, 1994)
"Normal mammalian pregnancy is confronted with a great number of self (autoimmune) and foreign (alloimmune) antigens that modulate the immune system of the mother."	2.38	Current status of immunologic recurrent pregnancy loss. ( Coulam, CB; Stern, JJ, 1993)
"Autoimmune thrombocytopenic purpura is the most common autoimmune disorder encountered in the pregnant patient."	2.37	Autoimmune thrombocytopenic purpura: current concepts and recommended practices. ( Files, JC; Martin, JN; Morrison, JC, 1984)
"Hypoglycemia was secondary to autoantibodies to the insulin receptor that were detected in the patient's serum."	2.37	Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus. ( Borenstein, DG; Moller, DE; Ratner, RE; Taylor, SI, 1988)
" Preliminary results seem to indicate, that the dosage used may be reduced slowly and therapy finally stopped after 3-4 years of treatment in most patients."	2.36	[Therapy of chronic hepatitis (author's transl)]. ( Arnold, W; Meyer zum Büschenfelde, KH, 1981)
"Pemphigus is not a contraindication to vaccination, although it may be worse or present as a first onset."	1.91	Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report. ( Khalayli, N; Kudsi, M; Omar, A, 2023)
"Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves."	1.62	COVID-19 IgG-related autoimmune inflammatory necrotizing myositis. ( Ayesha, B; Koyoda, S; Veyseh, M, 2021)
"Bullous pemphigoid is a common autoimmune blistering disorder, characterized by sub-epidermal bullae formation, that tends to affect older patients."	1.56	[EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB]. ( Molho-Pessach, V; Neumark, M; Tal, Y; Zlotogorski, A, 2020)
"Thymectomy is considered an effective treatment for myasthenia gravis but the benefit is not immediate."	1.56	[Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients]. ( Alba-Isasi, MT; Arroyo-Tristán, A; Cabrera-Maqueda, JM; Hernández, R; Morales-Ortiz, A, 2020)
"BACKGROUND Epidermolysis bullosa acquisita is a rare, subepithelial bullous disorder, which is distinguished from other autoimmune blistering diseases by the production of antibodies against type VII collagen."	1.56	Epidermolysis Bullosa Acquisita: A Case Report. ( Kumetz, EA; Meyerle, JH; Rivard, SC, 2020)
"Autoimmune myelofibrosis is a distinct clinicopathological entity that occurs with autoimmune disorders."	1.51	Autoimmune myelofibrosis: a rare haematological involvement in systemic lupus erythematosus. ( Belfeki, N; Declerck, D; Diamantis, S; Shankarasivam, G, 2019)
"Relapses are common in type 1 AIP after steroid treatment."	1.48	Prediction and Management for Relapse of Type 1 Autoimmune Pancreatitis After Initial Steroid Treatment: A Long-Term Follow-up From China. ( Hao, L; Hu, LH; Li, ZS; Lin, H; Liu, PP; Meng, QQ; Pan, J; Qian, W; Wang, LW; Xin, L, 2018)
"Epidermolysis bullosa acquisita is a chronic subepidermal blistering disease associated with autoimmunity to type-VII collagen within anchoring fibrils located at the dermo-epidermal junction."	1.46	A rare occurrence of epidermolysis bullosa acquisita in a patient with retroviral disease. ( Aditi, C; Chitra, N; Swagata, T; Uddhao, Z, 2017)
"However, cytopenias from autoimmune myelofibrosis (AIMF) are extremely uncommon in SLE, with less than 40 reported cases in the literature."	1.43	Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil. ( Chowdhary, VR; Davis, MD; Makol, A; Ungprasert, P, 2016)
"DiGeorge syndrome is the most common chromosome microdeletion disease."	1.43	[Autoimmune disorder secondary to DiGeorge syndrome: a long-term follow-up case report and literature review]. ( Guo, JQ; Hua, Y; Lu, XT; Sun, Q; Xie, Y; Zhao, WH, 2016)
"An autoimmune disease was present in seven (29%) cases."	1.42	Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015)
"Steroid was given as the treatment after relapse in most of the patients and the total remission rate at the end of follow-up was 96."	1.40	Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. ( Chang, XJ; He, YX; Hu, LH; Jin, G; Jin, ZD; Li, ZS; Liao, Z; Shao, CW; Xin, L; Zhang, QH; Zheng, JM; Zhu, XF; Zou, DW; Zuo, CJ, 2014)
"Autoimmune pancreatitis is a rare disorder characterized by the systemic deposition of IgG4 plasma cells."	1.39	Renal lesions in autoimmune pancreatitis: diffusion weighted magnetic resonance imaging for assessing response to corticosteroid therapy. ( Akshintala, VS; Halappa, VG; Kamel, IR; Singh, VK; Zaheer, A, 2013)
"We describe our experience with treatment of relapses and maintenance of remission using steroid-sparing immunomodulators (IMs) and induction of remission using rituximab (RTX)."	1.39	Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. ( Chari, ST; Clain, JE; Gleeson, FC; Hart, PA; Klebig, RR; Levy, MJ; Pearson, RK; Petersen, BT; Smyrk, TC; Sugumar, A; Takahashi, N; Topazian, MD; Vege, SS; Witzig, TE, 2013)
" In RA, the risk of combined fractures was associated with an average daily dosage of prednisone equivalents >10 mg/day at baseline compared with no glucocorticoid (HR 1."	1.39	Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. ( Arbogast, PG; Chen, L; Curtis, JR; Delzell, E; Griffin, MR; Grijalva, CG; Herrinton, L; Kawai, VK; Liu, L; Mitchell, EF; Ouellet-Hellstrom, R; Solomon, DH; Stein, CM, 2013)
"Prednisone was initiated after making the diagnosis of ISD."	1.38	Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. ( Bastacky, S; Craig, F; Jindal, N; Krasinskas, A; Liang, KV; Passero, C; Yadav, D, 2012)
"Autoimmune limbic encephalitis is a rare disorder, characterised by the subacute onset of seizures, short-term memory loss, and psychiatric and behavioural symptoms."	1.38	[Autoimmune limbic encephalitis: importance of early diagnosis and treatment]. ( Hartong, EG; Meulstee, J; Mulleners, WM; van Vliet, J, 2012)
"Seven children who presented with sensorineural hearing loss and were diagnosed with autoimmune inner ear disease."	1.37	Autoimmune inner ear disease in children. ( Huang, NC; Sataloff, RT, 2011)
"The probability of AIP recurrence was assessed by using Kaplan-Meier curves and the unadjusted Cox model."	1.37	Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. ( Bonatti, M; Frulloni, L; Graziani, R; Manfredi, R; Mantovani, W; Pozzi Mucelli, R, 2011)
"Differentiation of pemphigoid gestationis from pruritic urticarial papules and plaques of pregnancy is essential because management and outcomes differ."	1.36	Pemphigoid gestationis. ( Kamino, H; Lu, PD; Ralston, J; Stein, JA, 2010)
"The links between myelofibrosis and autoimmunity are discussed."	1.35	[Autoimmune myelofibrosis with dermatomyositis]. ( Delfraissy, JF; Ghosn, J; Goujard, C; Lambotte, O; Lazure, T; Sahali, S, 2009)
"To describe a case of acute nonherpetic limbic encephalitis (LE) with negative testing for antibodies directed against onconeuronal and cell membrane antigens, including voltage-gated potassium channels and N-methyl-D-aspartate receptor, that showed a dramatic response to immune therapy."	1.35	Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies. ( Andreetta, F; Marra, C; Masciullo, M; Modoni, A; Silvestri, G; Spinelli, P; Tartaglione, T; Tonali, P, 2009)
"Satoyoshi syndrome is a rare multisystemic disease of presumed autoimmune etiology characterized by progressive painful intermittent muscle spasms, diarrhea frequently associated with malabsorption, alopecia, skeletal abnormalities and endocrine disorders with a poor long-term prognosis due to early crippling."	1.35	[Satoyoshi syndrome: report of one case]. ( Castiglioni, C; Díaz, A; Hernández, C; Mericq, V; Moënne, K; Salvador, F, 2009)
"PFAPA syndrome is the most frequent cause of recurrent fever and is diagnosed based on unspecific criteria."	1.35	[Periodic fever in children: keep in mind the PFAPA syndrome]. ( Hofer, M; Rossetti, G, 2008)
"Dermatomyositis is an autoimmune condition that results in significant morbidity and mortality through effects on muscle and skin."	1.33	Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis. ( Arbiser, JL; Nadiminti, U, 2005)
"A patient with a conjunctival blister was diagnosed with pemphigus vulgaris by immunofluorescence tests performed on a conjunctival biopsy."	1.33	[Conjunctival blistering associated with pemphigus vulgaris: report of a case]. ( Alvarez, MA; Bianciotto, C; Herreras Cantalapiedra, JM; Méndez Díaz, MC, 2005)
"She was also diagnosed as having a myelofibrosis with myeloid metaplasia (MMM)."	1.33	Endolymphatic hydrops as a cause of audio-vestibular manifestations in relapsing polychondritis. ( Horii, A; Kubo, T; Mitani, K; Mizuki, M; Murata, J; Tamura, M, 2006)
"Pemphigoid gestationis is an acute autoimmune subepidermal bullous dermatosis which occurs during pregnancy and post partum."	1.33	[Pemphgoid gestationis. A report of 30 cases]. ( Fazaa, B; Kamoun, MR; Mokhtar, I; Triki, S; Zeglaoui, F, 2006)
"A woman with scleroderma and classic polyarteritis nodosa (PAN) who developed idiopathic myelofibrosis (IM) is reported."	1.32	Idiopathic myelofibrosis associated with classic polyarteritis nodosa. ( Abelló, D; Arellano-Rodrigo, E; Camós, M; Cervantes, F; Ferrer, A; Grau, JM; Muntañola, A, 2003)
"Pemphigus vulgaris is a potentially fatal autoimmune blistering disease that is rare in childhood."	1.32	Pemphigus vulgaris: the eyes have it. ( Merchant, S; Weinstein, M, 2003)
"Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is characterized by an acquired immune defect that can cause autoimmune complications, including anemia and thrombocytopenia."	1.32	Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. ( Kyasa, MJ; Parrish, RS; Schichman, SA; Zent, CS, 2003)
"One year later, the patient had a new recurrence and was treated with mycophenolate mofetil , improving his clinical situation."	1.32	[Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis]. ( Bueno, B; Espejo, B; González, E; Gutiérrez, E; Martínez, A; Torres, A; Valentín, M, 2004)
"The authors present a case of Kikuchi's disease associated with systemic lupus erythematosus (SLE) and autoimmune-like hepatitis."	1.32	Kikuchi's disease associated with systemic lupus erythematosus and autoimmune-like hepatitis. ( Ardeleanu, C; Atanasiu, C; Niţescu, D; Stăniceanu, F; Tănăsescu, C, 2003)
"The overlapping syndrome of systemic lupus erythematosus, autoimmune hepatitis, and autoimmune hyperlipidemia is discussed."	1.31	Autoimmune hyperlipidemia in a child with autoimmune hepatitis. ( Betzhold, J; Merati, S; Rumbo, C; Shneider, BL, 2002)
"We propose that autism may be part of the autoimmune disease spectrum of ALPS in this child, and this case represents a novel manifestation and target organ involvement in this disease."	1.31	Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. ( Arnold, S; Chatila, T; Shenoy, S, 2000)
"A 34-yr-old woman with Graves' disease and active ophthalmopathy who was found to be positive for ACA and to have high PRA, low aldosterone levels, and normal basal ACTH and cortisol levels, but impaired cortisol response to ACTH was studied."	1.31	Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report. ( Abbate, G; Bellastella, A; Bizzarro, A; Bizzarro, E; Coronella, C; De Bellis A, A; Falorni, A; Forini, F; Laureti, S; Perrino, S, 2001)
"Dapsone was the most commonly used drug (51 patients), followed by methotrexate (24 patients), azathioprine (23 patients), and cyclophosphamide (15 patients); prednisone, always given as adjunctive treatment, was used in 17 patients."	1.31	The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. ( Ahmed, AR; Baltatzis, S; Foster, CS; Miserocchi, E; Roque, MR, 2002)
" Improved hormone bioavailability was further evidenced by the reduction in the hypoglycemic delay after i."	1.30	Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome. ( Belloni, C; Beretta, A; Dosio, F; Dozio, N; Fazio, F; Pozza, G; Sartori, S; Sarugeri, E; Savi, A; Scavini, M; Sodoyez, JC, 1998)
"Autoimmune cholangitis is a rare cause of chronic liver disease which has recently been described and associates the clinical, biological, and histological patterns of primary biliary cirrhosis without serum anti-mitochondrial antibodies."	1.30	[Autoimmune cholangitis successfully treated with corticotherapy. One case]. ( Algayres, JP; Bili, H; Castagne, C; Coutant, G; Daly, JP; Gros, P; Mitry, E; Nizou, JY; Vergeau, B, 1998)
"Diagnosis of autoimmune sensorineural hearing loss was established."	1.30	Acute autoimmune sensorineural hearing loss associated with Crohn's disease. ( Bachmeyer, C; Cadranel, JF; Coutarel, P; Dhôte, R; Laurette, F; Leclerc-Landgraf, N; Médioni, J; Mougeot-Martin, M, 1998)
"Azathioprine-treated dogs had no significant changes in SIg levels or lymphocyte subpopulations."	1.30	The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogs. ( Kaushik, A; Kruth, SA; Rinkardt, NE, 1999)
"Identifying patients with autoimmune premature ovarian failure presents the opportunity to restore ovarian function by treating these patients with the proper immune modulation therapy."	1.30	Treatment of autoimmune premature ovarian failure. ( Braddock, DT; Kalantaridou, SN; Nelson, LM; Patronas, NJ, 1999)
"We describe congestive heart failure caused by autoimmune myocarditis in a patient with primary Sjögren's syndrome."	1.30	Myocarditis and primary Sjögren's syndrome. ( Levin, MD; Markusse, HM; Zoet-Nugteren, SK, 1999)
"Sixty-five percent of the patients with sudden deafness also had cross-reacting antibodies (27, 45, 50, 80 kD)."	1.29	Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. A reappraisal of immune reactivity in inner ear disorders. ( Hanada, T; Meeuwsen, F; Veldman, JE, 1993)
"Autoimmune chronic active hepatitis is traditionally treated with corticosteroids, or corticosteroids with azathioprine."	1.29	Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. ( Narkewicz, M; Pinto, PC; Sherman, KE, 1994)
"This patient later developed MCTD."	1.29	A HTLV-I carrier who showed various symptoms and antibodies of autoimmune diseases. ( Hashimoto, K; Hashimoto, M; Kawata, S; Mizuki, M; Nojima, J; Okamoto, Y; Sakata, K; Shibano, M; Tagawa, S; Takatsuki, K, 1993)
"Liver histology shows primary biliary cirrhosis coexisting with varying degrees of parenchymal inflammation."	1.29	Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? ( Alvarez, F; Colombato, LA; Côté, J; Huet, PM, 1994)
"The management of autoimmune sensorineural hearing loss (SNHL) continues to challenge the otologist."	1.29	Methotrexate therapy for autoimmune hearing loss: a preliminary report. ( Sismanis, A; Thompson, T; Willis, HE, 1994)
"Four epidemiologic types of Kaposi sarcoma (KS) are known: classic KS, endemic African KS, epidemic or acquired immunodeficiency syndrome-related KS, and KS associated with immunosuppressive therapy."	1.29	The appearance of Kaposi sarcoma during corticosteroid therapy. ( David, M; Hodak, E; Sandbank, M; Trattner, A, 1993)
"Cryptogenic chronic active hepatitis may be an autoimmune or viral disease."	1.29	The nature and prognosis of severe cryptogenic chronic active hepatitis. ( Carpenter, HA; Czaja, AJ; Homburger, HA; Moore, SB; Santrach, PJ, 1993)
"The authors reviewed the clinical records of 602 patients with ocular inflammatory disease treated with immunosuppressive drug therapy and/or systemic corticosteroids for adverse systemic effects while undergoing therapy."	1.29	Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. ( Akova, YA; Christen, WG; Foster, CS; Messmer, E; Rodriguez, A; Tamesis, RR, 1996)
"A 10-year-old male with severe aplastic anemia following allogeneic BMT developed a hemolytic crisis on post-BMT day 67."	1.29	Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide. ( Azuma, E; Hanada, M; Hiratake, S; Komada, Y; Nagai, M; Nishihara, H; Sakurai, M, 1996)
"A patient with longstanding Hashimoto's thyroiditis who was treated with L-thyroxine at a dosage of 0."	1.29	Graves' disease and autoimmune factor VIII deficiency. ( Goldstein, ML; Sievert, R; Surks, MI, 1996)
"Systemic symptoms of Hodgkin's disease were present for 6 months, and rapidly developing patchy hair loss of the scalp was present for 2 weeks prior to presentation."	1.28	Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy. ( Berk, MA; Chan, PD; Kucuk, O; Singh, S, 1992)
"We conclude that chronic ulcerative colitis can coexist with severe autoimmune hepatitis in the absence of primary sclerosing cholangitis or hepatitis C infection."	1.28	Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. ( Carpenter, HA; Czaja, AJ; Perdigoto, R, 1992)
"Prednisone was used in 17 cases, high dosage of methylprednisolone in 8 (in one case twice), azathioprine in 11 and cyclophosphamide in 10."	1.28	Immunosuppressive treatment for juvenile myasthenia gravis. ( Badurska, B; Ryniewicz, B; Strugalska, H, 1992)
"Azathioprine treatment reduced the aCL titer in the other patient, without fully normalizing it."	1.28	Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications. ( Engler, H; Lang, B; Peter, HH; Rump, JA, 1991)
"In a 35-year-old man, acute autoimmune hemolytic anemia (AIHA) was diagnosed in 1960; until 1965 he was free of disease, when he abruptly developed TTP and failed to respond to blood transfusions and corticosteroids."	1.28	Late appearance of thrombotic thrombocytopenic purpura after autoimmune hemolytic anemia and in the course of chronic autoimmune thrombocytopenic purpura: two case reports. ( Hurwitz, N; Krupsky, M; Resnitzky, P; Sarel, R, 1991)
"Agranulocytosis is a very rare complication of this autoimmune rheumatic disease as opposed to leucopenia."	1.28	Agranulocytosis in a patient with primary Sjögren's syndrome. ( Alusík, S; Korínková, P; Neuwirtová, R; Pavelka, K; Petrasovicová, V; Trnavský, K, 1990)
"We conclude that patients with severe chronic active hepatitis who have been fully screened for etiologic factors cannot be distinguished from patients with autoimmune disease of comparable severity."	1.28	Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. ( Czaja, AJ; Hay, JE; Rakela, J, 1990)
"From 1975 to 1986 we studied 12 nonhemophiliac and 5 hemophiliac patients with factor VIII inhibitor treated with FVIII-CVP and followed at our clinic."	1.28	Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. ( Chiu, AY; Larcada, AF; Lian, EC, 1989)
"In severe sporadic chronic active hepatitis of uncertain etiology, a clinically and prognostically distinct subgroup reflective of a possible autoimmune disorder cannot be defined."	1.27	Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. ( Baggenstoss, AH; Czaja, AJ; Davis, GL; Ludwig, J; Taswell, HF, 1983)
" Flare-ups of autoimmune ear disease are best managed by increasing steroid dosage or adding cytotoxic medications."	1.27	Practical versus theoretical management of autoimmune inner ear disease. ( Barna, BP; Calabrese, LH; Hughes, GB; Kinney, SE, 1984)
"Most autoimmune diseases are responsive to corticosteroids administered in dosages sufficient to shut off the inflammatory process."	1.27	Corticosteroids in autoimmune disease. ( Fauci, AS, 1983)
"Medical treatment for facial palsy includes an accurate diagnosis and reliable estimate of prognosis as well as appropriate medication."	1.27	Current medical treatment for facial palsy. ( Adour, KK; Hetzler, DG, 1984)
"An 80-year-old woman with eosinophilic fasciitis (EF) is presented."	1.27	Eosinophilic fasciitis. Report of a case with features of other autoimmune disease. ( Boiesen, M; Keiding, LM; Thomsen, K, 1983)
"Seventeen children with chronic active hepatitis and high serum titers of smooth-muscle or liver-kidney microsomal antibodies were given prednisone and azathioprine."	1.27	Treatment of autoimmune chronic active hepatitis in childhood. ( Alagille, D; Bernard, O; Hadchouel, M; Hadchouel, P; Maggiore, G; Odievre, M, 1984)
"An unusual autoimmune agranulocytosis featured intense plasmacytosis, hyperglobulinemia, and total absence of myeloid precursors."	1.27	An unusual case of autoimmune agranulocytosis with total absence of myeloid precursors: demonstration of diverse sources of R binder for cobalamin in plasma and secretions. ( Carmel, R, 1983)
"All had recurrences with five having two or more."	1.27	Acute and subacute orbital myositis. ( Dresner, SC; Kennerdell, JS; Slamovits, TL; Weinstein, GS, 1983)
"Also known as "pulseless disease" and "aortic arch syndrome," Takayasu's disease involves narrowing of the aortic arch and its branches."	1.27	Sensorineural hearing loss associated with Takayasu's disease. ( Brookler, KH; Siglock, TJ, 1987)
" Increasing the Cs dosage induced a remission again."	1.27	A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine. ( Freen, M; Hart, HC; Kerckhaert, JA; Kraaijenhagen, RJ; van de Wiel, A; Verdel, G, 1988)
"Pregnancy in chronic active hepatitis and cirrhosis is rare."	1.27	Pregnancy in chronic active hepatitis with cirrhosis. ( Charles, C; Donaldson, EK; Hall, JS; Hanchard, B; Lee, MG, 1987)
"Symptomatic relapses of autoimmune chronic active hepatitis during steroid withdrawal are well known."	1.27	Exquisite sensitivity to small decrements in corticosteroid dose in autoimmune chronic active hepatitis. ( Runyon, BA, 1987)
"Treatment with prednisone and azathioprine improved the liver condition in 16 of the 18 patients given treatment."	1.27	Liver disease associated with anti-liver-kidney microsome antibody in children. ( Alagille, D; Alvarez, F; Bernard, O; Hadchouel, M; Hadchouel, P; Homberg, JC; Maggiore, G; Odièvre, M, 1986)
"Fourteen patients with systemic lupus erythematosus had splenectomies done between 1960 and 1982 for treatment of severe thrombocytopenia."	1.27	Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. ( Greipp, PR; Hall, S; McCormick, JL; McKenna, CH; Michet, CJ, 1985)
"Treatment with prednisone and vincristine led to a rise in the platelet count to 100,000/mm3 after two months with no change in the splenomegaly."	1.27	Autoimmune thrombocytopenia in sarcoidosis. ( Greenberg, BR; Lawrence, HJ, 1985)
"Autoimmune thrombocytopenia has been recognized as a distinct entity in the dog and cat."	1.26	Autoimmune thrombocytopenia in dogs and cats. ( Jain, NC; Switzer, JW, 1981)
"Individuals with selective IgA deficiency should no longer be considered "normal"."	1.26	Selective IgA deficiency with multiple autoimmune disorders. ( Diamant, S; Hauser, GJ; Heiman, I; Laurian, L; Spirer, Z, 1981)
" There appeared to be some correlation between dosage and degree of apparent atrophy."	1.26	Steroids and apparent cerebral atrophy on computed tomography scans. ( Bentson, J; Reza, M; Wilson, G; Winter, J, 1978)
" Mortality and morbidity closely correlated with the corticosteroid dosage used to attain control."	1.26	Pemphigus: a 20-year review of 107 patients treated with corticosteroids. ( Nelson, CT; Rosenberg, FR; Sanders, S, 1976)
"of prednisone per day, were also tested."	1.25	Effect of plasma, steroids, or steroid products on the adhesion of human opsonized thrombocytes to human leukocytes. ( Karpatkin, S; Verp, M, 1975)
"In 50 to 60 percent of patients with systemic lupus erythematosus (SLE), a band of immunoglobulins beneath the epidermis of visibly normal skin."	1.25	The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. ( Gilliam, JN, 1975)
"Treatment with prednisone was followed by an improvement in bleeding time, although in vitro platelet function deteriorated."	1.25	Prednisone-induced hemostasis in a platelet function abnormality. ( Hathaway, WE; Hutter, JJ, 1975)
"At autopsy, generalized Hodgkin's disease of mixed cellularity was found."	1.25	Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease. ( Bastarache, A; Cazenave, JP; Gagnon, JA; Girouard, E, 1973)
"Nineteen cases of malignant lymphomata were selected for study from a group of about 1500 collected cases of malignant lymphomata because they showed histological evidence of non-infectious epithelioid-cell granulomata in one or more tissues."	1.25	Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. ( Brincker, H, 1972)

Research

Studies (574)

Authors

Clinical Trials (11)

Trial Overview

Trial Outcomes

Average Amount of Meal Per Day

Average Frequency of Meals Per Day

Timeframe	Studies, this research(%)	All Research%
pre-1990	218 (37.98)	18.7374
1990's	127 (22.13)	18.2507
2000's	107 (18.64)	29.6817
2010's	103 (17.94)	24.3611
2020's	19 (3.31)	2.80

Authors	Studies
Li, H	2
Gao, Y	2
Xie, L	1
Wang, R	1
Duan, R	1
Li, Z	1
Chen, B	2
Zhu, L	1
Wang, X	2
Su, W	1
Wang, JX	1
Wilkinson, M	1
Oldmeadow, C	1
Limaye, V	1
Major, G	1
Zlotnik, Y	1
Gadoth, A	1
Abu-Salameh, I	1
Horev, A	1
Novoa, R	1
Ifergane, G	1
Aikawa, NE	1
Kupa, LVK	1
Medeiros-Ribeiro, AC	1
Saad, CGS	1
Yuki, EFN	1
Pasoto, SG	1
Rojo, PT	1
Pereira, RMR	1
Shinjo, SK	3
Sampaio-Barros, PD	1
Andrade, DCO	1
Halpern, ASR	1
Fuller, R	1
Souza, FHC	1
Guedes, LKN	1
Assad, APL	1
Moraes, JCB	1
Lopes, MRU	1
Martins, VAO	1
Betancourt, L	1
Ribeiro, CT	1
Sales, LP	1
Bertoglio, IM	1
Bonoldi, VLN	1
Mello, RLP	1
Balbi, GGM	1
Sartori, AMC	1
Antonangelo, L	1
Silva, CA	1
Bonfa, E	1
Zhou, M	1
Qu, R	1
Yin, X	1
Qiu, Y	1
Peng, Y	1
Liu, B	1
Bi, H	1
Guo, D	1
Khalayli, N	1
Omar, A	1
Kudsi, M	1
Pan, L	1
Liu, J	1
Liu, C	1
Guo, L	1
Punaro, M	1
Yang, S	1
Ssemmanda, S	1
Musubire, AK	1
Oporto Caroca, JI	1
Oporto Caroca, J	1
Lee, J	1
Seiffert-Sinha, K	1
Attwood, K	1
Sinha, AA	1
Neumark, M	1
Tal, Y	1
Zlotogorski, A	1
Molho-Pessach, V	1
Christin, A	1
de Leval, L	1
Obeid, M	1
Taillefer, VT	1
Pigeon, M	1
Chen, M	2
Larochelle, C	1
Florescu, M	1
Bélanger, K	1
Adam, JP	1
Cabrera-Maqueda, JM	1
Alba-Isasi, MT	1
Hernández, R	1
Arroyo-Tristán, A	1
Morales-Ortiz, A	1
Kumetz, EA	1
Meyerle, JH	1
Rivard, SC	1
Askanase, AD	1
Zhao, E	1
Zhu, J	1
Connolly-Strong, E	1
Furie, RA	1
Below, S	1
Bashir, M	1
Holton-Burke, R	1
Laurenzano, S	1
Phillips, S	1
Stover, LB	1
Radhakrishna, S	1
Khare, M	1
Veyseh, M	1
Koyoda, S	1
Ayesha, B	1
Žibřidová, K	1
Havlínová, B	1
Svobodová, E	1
Žák, P	1
Čáp, J	1
Gabalec, F	1
Wu, Q	2
Chang, J	1
Chen, H	2
Chen, Y	1
Yang, H	2
Fei, Y	2
Zhang, P	1
Zeng, X	2
Zhang, F	2
Zhang, W	2
Uddhao, Z	1
Aditi, C	1
Chitra, N	1
Swagata, T	1
Kim, M	1
Sadoughi, B	1
Zeng, XX	1
Tang, YL	1
Hu, KX	1
Wang, J	1
Zhu, LY	1
Liu, JY	1
Xu, J	1
Dumas, M	1
Hua, C	1
Hotz, C	1
Velter, C	1
Duong, TA	1
Maraffi, T	1
Ortonne, N	1
Hüe, S	1
Fardet, L	1
de Prost, N	1
Wolkenstein, P	1
Ingen-Housz-Oro, S	1
Chosidow, O	1
Fujita, Y	1
Nakazato, T	1
Ito, C	1
Masuda, K	1
Osada, Y	1
Aisa, Y	1
Mori, T	1
Zhang, K	1
Liu, X	2
Yi, L	1
Li, J	1
Shi, J	1
Liu, T	1
Wanner, D	1
Bohn, JP	1
Rudzki, J	1
Stockhammer, G	1
Steurer, M	1
Moffa, S	1
Improta, I	1
Rocchetti, S	1
Mezza, T	1
Giaccari, A	1
Xin, L	2
Meng, QQ	1
Hu, LH	2
Lin, H	1
Pan, J	1
Hao, L	1
Liu, PP	1
Qian, W	1
Wang, LW	1
Li, ZS	2
Deng, X	1
Fang, R	1
Zhang, J	1
Li, R	1
Soriano Rios, A	1
Paredes, H	1
Hernández-Calleros, J	1
Uscanga-Domínguez, L	1
Peláez-Luna, M	1
Belfeki, N	1
Shankarasivam, G	1
Declerck, D	1
Diamantis, S	1
Olivo Pallo, PA	1
de Souza, FHC	2
Miossi, R	2
de Araújo, DB	1
Vilela, VS	1
Bezerra, MC	1
Simões, RS	1
Bernardo, WM	1
da Cunha, BM	1
Mouton, C	1
Leroux, L	1
Bonnet, G	1
Seguy, B	1
Lafargue, A	1
Baulier, G	1
Castet, S	1
Fiore, M	1
Mithoowani, S	1
Arnold, DM	1
Ramirez, GA	1
Rovere-Querini, P	1
Blasi, M	1
Sartorelli, S	1
Di Chio, MC	1
Baldini, M	1
De Lorenzo, R	1
Bozzolo, EP	1
Leone, R	1
Mantovani, A	1
Manfredi, AA	1
Tombetti, E	1
Hasan, S	1
Abushahin, A	1
Prayson, R	1
Kilani, A	1
He, C	1
Lee, JS	1
Cool, CD	1
Wicklund, MP	1
Fischer, A	1
Yuan, JT	1
Said, J	1
Blackwell, KE	1
Harris, DA	1
Mikulec, AA	1
Carls, SL	1
Matsuoka, AJ	1
Harris, JP	4
Woo, SB	1
Stone, JH	2
Kraft, S	1
Zaheer, A	1
Halappa, VG	1
Akshintala, VS	1
Singh, VK	1
Kamel, IR	1
Gullo, D	1
Evans, JL	1
Sortino, G	1
Goldfine, ID	1
Vigneri, R	1
Lin, W	1
Wang, Q	1
Wang, L	1
Zheng, W	1
Fei, G	1
Li, P	2
Li, YZ	1
Zhao, Y	1
Anderson, L	1
Bhatia, V	1
Mei, JH	1
Cai, XJ	1
Liang, X	1
Wu, JG	1
Zheng, WL	1
Zhang, QW	1
Qu, LM	1
Liu, YH	2
Brigstock, DR	1
Wen, XY	1
Liu, YF	1
Li, YJ	1
Gao, RP	1
Heusele, M	1
Clerson, P	1
Guery, B	1
Lambert, M	1
Launay, D	2
Lefevre, G	1
Morell-Dubois, S	1
Maillard, H	1
Le Gouellec, N	1
Hatron, PY	1
Hachulla, E	2
Buijs, J	1
van Heerde, MJ	1
Rauws, EA	1
de Buy Wenniger, LJ	1
Hansen, BE	1
Biermann, K	1
Verheij, J	1
Vleggaar, FP	1
Brink, MA	1
Beuers, UH	1
Kuipers, EJ	1
Bruno, MJ	1
van Buuren, HR	1
Mekinian, A	2
Costedoat-Chalumeau, N	1
Masseau, A	1
Botta, A	1
Chudzinski, A	1
Theulin, A	1
Emmanuelli, V	1
De Carolis, S	1
Revaux, A	2
Nicaise, P	2
Cornelis, F	2
Subtil, D	1
Montestruc, F	1
Bucourt, M	2
Chollet-Martin, S	2
Carbillon, L	2
Fain, O	2
Berger, Z	1
Flanagan, EP	1
Chowdhary, VR	2
McCarthy, JT	2
Smyrk, TC	3
Chari, ST	5
Kumar, N	1
Benadiba, J	1
Robitaille, N	1
Lambert, G	1
Itaj, NK	1
Pastore, Y	1
Pagnini, I	1
Simonini, G	1
Cavalli, L	1
la Marca, G	1
Iuliano, A	1
Brandi, ML	1
Bellisai, F	1
Frediani, B	1
Galeazzi, M	1
Cantarini, L	1
Cimaz, R	2
Lachassinne, E	1
He, YX	1
Zhu, XF	1
Zhang, QH	1
Zou, DW	1
Jin, ZD	1
Chang, XJ	1
Zheng, JM	1
Zuo, CJ	1
Shao, CW	1
Jin, G	1
Liao, Z	1
Kervarrec, T	1
Binois, R	1
Bléchet, C	1
Estève, É	1
Bursztyn, LL	1
Belrose, JC	1
Coupland, SG	1
Fraser, JA	1
Proulx, AA	1
Goh, TL	1
Cicovic, A	1
Sapsford, T	1
Semple, D	1
Yadav, D	2
Chahal, P	1
Hughes, AL	1
Comer, BT	1
Alexander, MP	1
Fervenza, FC	1
De Vriese, AS	1
Smith, RJH	1
Nasr, SH	1
Cornell, LD	1
Herrera Hernandez, LP	1
Zhang, Y	2
Sethi, S	1
Fan, RY	1
Sheng, JQ	1
Lurz, E	1
Gonska, T	1
Ungprasert, P	1
Davis, MD	1
Makol, A	1
Krause, ML	1
Yi, ES	2
Warrington, KJ	1
Steinweg, SA	1
Gaspari, AA	1
Longo, L	1
Greco, A	1
Rea, A	1
Lo Vasco, VR	1
De Virgilio, A	1
De Vincentiis, M	1
Mammen, AL	1
Kamisawa, T	2
Kuruma, S	1
Chiba, K	1
Dejaco, C	1
Matteson, EL	2
Buttgereit, F	1
Yan, TM	1
He, CX	1
Hua, BL	1
Li, L	1
Jin, HZ	1
Zuo, YG	1
Zahiu, DC	1
Mocanu, C	1
Rimbaş, M	1
Xie, Y	1
Guo, JQ	1
Hua, Y	1
Zhao, WH	1
Sun, Q	1
Lu, XT	1
Jamnitski, A	1
van Hall, O	1
de Vries, N	1
van der Valk, P	1
Lems, WF	1
van der Horst-Bruinsma, IE	1
Chen, D	1
Lin, CY	1
Han, X	1
Lu, ZH	1
Chang, XY	1
Duan, MH	1
Zelada, H	1
Gamarra, D	1
Arbañil, H	1
Manrique, H	1
Sahali, S	1
Ghosn, J	1
Lazure, T	1
Goujard, C	1
Delfraissy, JF	1
Lambotte, O	1
Di Leo, E	1
Dambra, PP	1
Capuzzimati, L	1
Giovine, A	1
Guerriero, S	1
Nettis, E	1
Vacca, A	1
Decker, DA	1
Heilman, KM	1
Sahani, DV	1
Sainani, NI	1
Deshpande, V	2
Shaikh, MS	1
Frinkelberg, DL	1
Fernandez-del Castillo, C	1
Ferreyra, HA	1
Jayasundera, T	1
Khan, NW	1
He, S	1
Lu, Y	1
Heckenlively, JR	1
Modoni, A	1
Masciullo, M	1
Spinelli, P	1
Marra, C	1
Tartaglione, T	2
Andreetta, F	1
Tonali, P	1
Silvestri, G	1
Borges da Costa, J	1
Mayer-da-Silva, A	1
Soares de Almeida, LM	1
Marques Gomes, M	1
Alexander, TH	1
Weisman, MH	2
Derebery, JM	2
Espeland, MA	3
Gantz, BJ	3
Gulya, AJ	3
Hammerschlag, PE	2
Hannley, M	2
Hughes, GB	4
Moscicki, R	2
Nelson, RA	2
Niparko, JK	3
Rauch, SD	3
Telian, SA	3
Brookhouser, PE	3
Shakov, R	1
DePasquale, JR	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Immunogenicity and Safety of the CoronaVac Vacccine in Patients With Autoimmune Rheumatic Diseases and People Living With HIV/AIDS[NCT04754698]	Phase 4	2,067 participants (Anticipated)	Interventional	2021-02-09	Active, not recruiting
Effect of Steroids on Post-tonsillectomy Morbidities[NCT02401529]	Phase 2	100 participants (Actual)	Interventional	2013-01-31	Completed
A Pilot Trial of Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss[NCT02828033]	Early Phase 1	10 participants (Anticipated)	Interventional	2017-02-01	Recruiting
A Phase II Placebo Controlled Study of the Effects of Anakinra (Kineret) in Subjects With Corticosteroid-Resistant/Intolerant Meniere's Disease (CR-MD) and Corticosteroid-Resistant/Intolerant Autoimmune Inner Ear Disease Disease (CR-AIED)[NCT03587701]	Phase 2	57 participants (Anticipated)	Interventional	2019-01-03	Recruiting
A Large Sample Follow-up Study of Long-term Complications of Acute Pancreatitis[NCT02305914]		1,300 participants (Anticipated)	Observational	2014-11-30	Recruiting
An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome[NCT00101829]	Phase 1	12 participants (Actual)	Interventional	2004-04-30	Completed
Pancreatic Duct Evaluation in Autoimmune Pancreatitis: Intraindividual Comparison of MR Pancreatography at 3.0 T and 1.5 T[NCT01773031]		30 participants (Actual)	Observational	2013-01-31	Completed
Childhood Onset Psychiatric Disorders: A Placebo Controlled Double-Blind Crossover Trial of Intravenous Immunoglobulin (IVIg)[NCT00001768]	Phase 3	10 participants	Interventional	1997-10-31	Completed
Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea[NCT00615797]		20 participants (Actual)	Interventional	2002-05-31	Completed
Pattern and Frequency of Non-epileptic Involuntary Movements. Hospital-based Study[NCT04083586]		144 participants (Actual)	Observational	2020-01-15	Completed
Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325]	Phase 1/Phase 2	8 participants (Actual)	Interventional	2005-03-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Intervention	participants (Number)
	inadequate	adequate
IV Dexamethasone and Oral Prednisolone	16	34
Placebo	27	23

average frequency of meals (1 meal, 2 meals, if more specify) (NCT02401529)
Timeframe: average number of meals consumed per day for the 1st three days post-surgery

Duration of Post-operative Nausea

Intervention	participants (Number)
	1 meal	2 meals	3 meals
IV Dexamethasone and Oral Prednisolone	2	20	28
Placebo	1	34	15

Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify) (NCT02401529)
Timeframe: 7 days

Duration of Post-operative Pain

Intervention	participants (Number)
	no nausea	one day	two days	three days
IV Dexamethasone and Oral Prednisolone	33	3	14	0
Placebo	21	8	15	6

4 selections (1 day, 2 days, 3 days, if more specify) (NCT02401529)
Timeframe: number of days at which pain was experienced within the the 1st sevn days post -surgery

Maximum Severity of Post-operative Pain

Intervention	participants (Number)
	one day	two days	three days
IV Dexamethasone and Oral Prednisolone	36	11	3
Placebo	23	19	8

5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting) (NCT02401529)
Timeframe: The severest pain grade felt within a week

Occurence of Post-operative Nausea

Occurence of Postoperative Vomiting

Onset of 1st Post-operative Oral Intake

Intervention	participants (Number)
	Low disability and low intensity	high disability and moderate intensity	high disability and high intensity
IV Dexamethasone and Oral Prednisolone	37	13	0
Placebo	26	21	3

Intervention	participants (Number)
	yes	no
IV Dexamethasone and Oral Prednisolone	17	33
Placebo	29	21

Intervention	participants (Number)
	yes	no
IV Dexamethasone and Oral Prednisolone	25	25
Placebo	36	14

feeding onset (1st day i. surgery day, 2nd day, 3rd day) (NCT02401529)
Timeframe: Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery

Onset of Post-operative Nausea

Intervention	participants (Number)
	surgery day	1st day after surgery
IV Dexamethasone and Oral Prednisolone	46	4
Placebo	37	13

Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day) (NCT02401529)
Timeframe: onset of 1st ocurence of nausea attack within the 1st week post-surgery

Total Number of Post-operative Vomiting Episodes

Intervention	participants (Number)
	no nausea	immediately	1st day	immediately and 1st day
IV Dexamethasone and Oral Prednisolone	33	10	4	3
Placebo	21	8	11	10

Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify) (NCT02401529)
Timeframe: total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery

B Cell Number at Week 24

Intervention	participants (Number)
	no vomiting	once	twice	three times	more than 3 times
IV Dexamethasone and Oral Prednisolone	25	13	7	4	1
Placebo	14	9	19	8	0

Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks

IgG Anti Bullous Pemphigoid (BP) 180 Measured in Units by ELISA at Week 24.

Intervention	B cells per microliter (Median)
Treated	3.99

IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks

Number of Days to Cessation of New Blister

Intervention	Elisa Units (Median)
Treated	40.5

The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year

Systemic Corticosteroid Dose of 25% of Starting Dose or 10 mg/Day by Week 24

Intervention	Days (Median)
Treated	57

Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks

Primary Safety Endpoint

Intervention	participants (Number)
Treated	7

The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year

Article	Year
Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy. Frontiers in immunology, 2023, Volume: 14 Topics: Adult; Autoimmune Diseases; Child; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids;	2023
Insulin autoimmune syndrome in a pregnant female: A rare case report. Medicine, 2017, Volume: 96, Issue:51 Topics: Abortion, Spontaneous; Adult; Autoimmune Diseases; Female; Follow-Up Studies; Gestational Age; Grave	2017
Multivisceral IgG4-related disease presenting as recurrent massive gastrointestinal bleeding: a case report and literature review. BMC gastroenterology, 2018, Sep-04, Volume: 18, Issue:1 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Diagnostic Errors; Digestive System Diseases; Duodena	2018
Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies. Advances in rheumatology (London, England), 2019, 01-22, Volume: 59, Issue:1 Topics: Adult; Autoimmune Diseases; Biomarkers; Brazil; Dermatomyositis; Exercise; Exercise Therapy; Glucoco	2019
First-Line Therapy for Immune Thrombocytopenia. Hamostaseologie, 2019, Volume: 39, Issue:3 Topics: Acute Disease; Adolescent; Adult; Autoimmune Diseases; Blood Platelets; Child; Child, Preschool; Dex	2019
Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System. Transfusion, 2015, Volume: 55, Issue:3 Topics: Adolescent; Aged; Autoimmune Diseases; Blood Safety; Contraceptives, Oral, Hormonal; Female; Headach	2015
Relapsing polychondritis: A clinical update. Autoimmunity reviews, 2016, Volume: 15, Issue:6 Topics: Autoimmune Diseases; Humans; Polychondritis, Relapsing; Prednisone	2016
Statin-Associated Autoimmune Myopathy. The New England journal of medicine, 2016, Feb-18, Volume: 374, Issue:7 Topics: Algorithms; Autoimmune Diseases; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibi	2016
The Treatment of IgG4-Related Diseases in the Hepatobiliary-Pancreatic System. Seminars in liver disease, 2016, Volume: 36, Issue:3 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Cholangiopancreatography, Endoscopic Retrograde; Chol	2016
[Diagnostics and treatment of polymyalgia rheumatica]. Zeitschrift fur Rheumatologie, 2016, Volume: 75, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoimmune Diseases; Diagnosis, Differential; Dos	2016
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review. The Journal of dermatology, 2017, Volume: 44, Issue:1 Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermo	2017
[Para-neoplastic autoimmune multi-organ syndrome associated with follicular lymphoma: a case report and literature review]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2016, Dec-14, Volume: 37, Issue:12 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoimmune D	2016
Autoimmune pancreatitis: case series and review of the literature. Annals of clinical and laboratory science, 2009,Spring, Volume: 39, Issue:2 Topics: Autoimmune Diseases; Cholangiopancreatography, Endoscopic Retrograde; Female; Humans; Immunoglobulin	2009
Postpartum-acquired haemophilia A: a description of three cases and literature review. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:6 Topics: Adult; Anemia; Autoantibodies; Autoimmune Diseases; Blood Transfusion; Combined Modality Therapy; Cu	2009
Autoimmune pancreatitis: report of two cases and literature review. Hepatobiliary & pancreatic diseases international : HBPD INT, 2009, Volume: 8, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoimmune Diseases; Biomarkers; Cho	2009
Azathioprine-induced liver injury in a patient with multiple autoimmune syndrome. The Journal of dermatological treatment, 2010, Volume: 21, Issue:6 Topics: Adult; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerativ	2010
New kid on the block? Autoimmune pancreatitis. Best practice & research. Clinical gastroenterology, 2010, Volume: 24, Issue:4 Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Diagnostic Imaging; Fe	2010
IgG4-related systemic disease in a Native American man. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:8 Topics: Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Cholangitis, Sclerosing; Dacryocystitis	2011
Therapeutic management and clinical outcome of autoimmune pancreatitis. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:9 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Diabetes Complications; Humans; Immunosuppressive Age	2011
Diagnosis and treatment of autoimmune hypophysitis: a short review. Journal of endocrinological investigation, 2011, Volume: 34, Issue:8 Topics: Adult; Autoimmune Diseases; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Pituitary Dis	2011
Childhood immune thrombocytopenia: a changing therapeutic landscape. Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:7 Topics: Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Child; Child, Preschool; Dexamethasone;	2011
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combin	2002
[Autoimmune hepatitis caused by acute hepatitis due to hepatitis A virus]. Gastroenterologia y hepatologia, 2002, Volume: 25, Issue:8 Topics: Acute Disease; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Autoa	2002
First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange. Journal of clinical apheresis, 2002, Volume: 17, Issue:4 Topics: Adult; Autoimmune Diseases; Colitis, Ulcerative; Female; Humans; Middle Aged; Plasma Exchange; Predn	2002
Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatric hematology and oncology, 2003, Volume: 20, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Atrophy; Autoimmune Diseases; Brain; Chromosome Deletion; Chromosomes	2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti	2003
[THE "LUPOID HEPATITIS" SYNDROME. A CONTRIBUTION TO THE PROBLEM OF THE NOSOLOGICAL CLASSIFICATION OF LIVER DISEASES WITH ANTINUCLEAR SERUM FACTORS. 4 PERSONAL CASES AND REVIEW OF THE LITERATURE]. Gastroenterologia, 1963, Volume: 100 Topics: Autoantibodies; Autoimmune Diseases; Blood Protein Electrophoresis; Classification; Fluorescent Anti	1963
Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. Journal of pediatric surgery, 2003, Volume: 38, Issue:11 Topics: Autoimmune Diseases; Azathioprine; Blood Sedimentation; Child; Combined Modality Therapy; Creatinine	2003
Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5 Suppl 3 Topics: Adult; Autoimmune Diseases; Combined Modality Therapy; Diagnosis, Differential; Hemorrhage; Humans;	2004
Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia : the official journal of the World Federation of Hemophilia, 2005, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived;	2005
[Cerebral abscess in an immunosuppressed patient]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:1 Topics: Autoimmune Diseases; Brain Abscess; Consciousness Disorders; Cyclophosphamide; Fatal Outcome; Female	2005
Autoimmune pancreatitis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2005, Volume: 9, Issue:1 Topics: Autoimmune Diseases; Glucocorticoids; Humans; Pancreatitis; Prednisone	2005
Autoimmune pancreatitis. The New England journal of medicine, 2006, Dec-21, Volume: 355, Issue:25 Topics: Adrenal Cortex Hormones; Algorithms; Autoimmune Diseases; Cholangiopancreatography, Endoscopic Retro	2006
Rituximab in autoimmune pancytopenia: a case report and review of literature. Annals of hematology, 2007, Volume: 86, Issue:12 Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived	2007
Autoimmune pancreatitis with retroperitoneal fibrosis which responded to steroid therapy but was complicated with refractory renal dysfunction. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:18 Topics: Autoimmune Diseases; Humans; Kidney Diseases; Male; Middle Aged; Pancreatitis; Prednisone; Retroperi	2007
[Therapy of chronic hepatitis (author's transl)]. Leber, Magen, Darm, 1981, Volume: 11, Issue:2 Topics: Autoimmune Diseases; Azathioprine; Chloroquine; Chronic Disease; Diagnosis, Differential; Hepatitis;	1981
Chronic active hepatitis. American family physician, 1984, Volume: 29, Issue:6 Topics: alpha 1-Antitrypsin Deficiency; Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Drug The	1984
[Crohn's disease: review of the acquisitions and problems of etiopathogenesis, histogenesis and therapy]. La Clinica terapeutica, 1981, Aug-15, Volume: 98, Issue:3 Topics: Adrenocorticotropic Hormone; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Autoimmun	1981
Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects. International journal of neurology, 1980, Volume: 14, Issue:1 Topics: Adrenal Cortex Hormones; Animals; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Human	1980
Bullous pemphigoid and pemphigus vulgaris. Annals of allergy, 1983, Volume: 50, Issue:3 Topics: Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Bandages; Bas	1983
Thrombocytopenia in the newborn. Seminars in perinatology, 1983, Volume: 7, Issue:3 Topics: Autoantibodies; Autoimmune Diseases; Blood Platelets; Blood Transfusion; Disseminated Intravascular	1983
Autoimmune thrombocytopenic purpura: current concepts and recommended practices. American journal of obstetrics and gynecology, 1984, Sep-01, Volume: 150, Issue:1 Topics: Acute Disease; Autoantibodies; Autoimmune Diseases; Blood Platelets; Blood Transfusion; Chronic Dise	1984
The price of immunotherapy. Current problems in surgery, 1981, Volume: 18, Issue:11 Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Cyclospori	1981
Cyclosporine for the treatment of pemphigus vulgaris. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:10 Topics: Autoimmune Diseases; Cyclosporine; Humans; Pemphigus; Prednisone; Remission Induction	1994
Immune-mediated inner ear disorders. Bailliere's clinical neurology, 1994, Volume: 3, Issue:3 Topics: Antibody Formation; Antigen-Antibody Reactions; Autoimmune Diseases; Blotting, Western; Cyclophospha	1994
[Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis]. Schweizerische medizinische Wochenschrift, 1994, Mar-26, Volume: 124, Issue:12 Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Hepatitis, Chronic; Humans; Immunosuppre	1994
Clinical, historic, and therapeutic features of cicatricial pemphigoid. A literature review and open therapeutic trial with corticosteroids. Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:4 Topics: Aged; Autoantibodies; Autoimmune Diseases; Basement Membrane; Clobetasol; Complement C3; Female; Hum	1993
Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. The American journal of clinical nutrition, 1994, Volume: 59, Issue:2 Suppl Topics: Adult; Aspirin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Humans; Lactation Disorders;	1994
Autoimmune myasthenia gravis. Hospital practice (Office ed.), 1993, Jan-15, Volume: 28, Issue:1 Topics: Adult; Age Factors; Antibody Formation; Autoimmune Diseases; Cyclosporine; Diagnosis, Differential;	1993
Current status of immunologic recurrent pregnancy loss. Current opinion in obstetrics & gynecology, 1993, Volume: 5, Issue:2 Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antilymphocyte Serum; Aspirin; Autoimmune Diseases	1993
Influence of treatment on the clinical course of pemphigus vulgaris. Journal of the American Academy of Dermatology, 1996, Volume: 34, Issue:4 Topics: Adjuvants, Pharmaceutic; Adult; Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Contraindicatio	1996
Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case. The Netherlands journal of medicine, 1996, Volume: 48, Issue:5 Topics: Autoantibodies; Autoimmune Diseases; Female; Glucocorticoids; Humans; Hypoglycemia; Insulin Antibodi	1996
Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus, 1996, Volume: 5, Issue:4 Topics: Adult; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents	1996
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Annals of neurology, 1995, Volume: 37 Suppl 1 Topics: Adult; Aged; Antigens, Bacterial; Autoantigens; Autoimmune Diseases; Campylobacter; Campylobacter In	1995
Paraneoplastic pemphigus. Advances in dermatology, 1997, Volume: 12 Topics: Adult; Anti-Inflammatory Agents; Autoantigens; Autoimmune Diseases; Autoimmunity; Cell Adhesion Mole	1997
[Autoimmune thrombocytopenia and pregnancy]. Minerva ginecologica, 1996, Volume: 48, Issue:12 Topics: Autoimmune Diseases; Female; Glucocorticoids; Humans; Platelet Count; Prednisone; Pregnancy; Pregnan	1996
[Therapy of dilated cardiomyopathies with and without inflammation]. Medizinische Klinik (Munich, Germany : 1983), 1998, Apr-15, Volume: 93, Issue:4 Topics: Adjuvants, Immunologic; Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammato	1998
Treatment of antiphospholipid syndrome in pregnancy. Lupus, 1998, Volume: 7 Suppl 2 Topics: Abortion, Habitual; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anticoagulants; Antiphospholi	1998
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. Journal of the American Academy of Dermatology, 1999, Volume: 40, Issue:5 Pt 1 Topics: Aged; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Glucoc	1999
Autoimmune liver disease. Current standards, future directions. Clinics in liver disease, 2001, Volume: 5, Issue:2 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangiti	2001
Allogeneic stem cell transplantation for Evans syndrome. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Autoimmune Di	2001
Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange. Journal of clinical apheresis, 2001, Volume: 16, Issue:4 Topics: Adult; Arthritis, Rheumatoid; Aspirin; Autoimmune Diseases; Blood Platelets; Combined Modality Thera	2001
Autoimmune bullous dermatoses: a review. American family physician, 2002, May-01, Volume: 65, Issue:9 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Family Practice; Humans; Prednisone; Skin Diseases, V	2002
Chronic active hepatitis: immunopathogenesis and immunotherapy. Israel journal of medical sciences, 1979, Volume: 15, Issue:3 Topics: Antibodies, Viral; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Carrier State; Chronic D	1979
Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine, 1976, Volume: 55, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cartilage; Cartilage, A	1976
Antiphospholipid syndrome: laboratory concerns, fetal loss, and pregnancy management. Seminars in perinatology, 1991, Volume: 15, Issue:3 Topics: Adrenal Cortex Hormones; Aspirin; Autoimmune Diseases; Female; Fetal Death; Heparin; Humans; Phospho	1991
Insulin dependent diabetes mellitus hypothesis of autoimmunity. Autoimmunity, 1991, Volume: 8, Issue:3 Topics: Animals; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclosporine; Cytotoxicity, Immunolo	1991
Stiff-person syndrome: an autoimmune disease. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:1 Topics: Autoantibodies; Autoimmune Diseases; Baclofen; Diazepam; Drug Administration Schedule; Drug Therapy,	1991
Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus. The American journal of medicine, 1988, Volume: 84, Issue:2 Topics: Autoantibodies; Autoimmune Diseases; Female; Humans; Hypoglycemia; Insulin Antibodies; Lupus Erythem	1988
[Dermatological news from America. I]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1970, Volume: 21, Issue:10 Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Autoimmune Diseases; Blister; Child;	1970
Idiopathic thrombocytopenic purpura. The Netherlands journal of medicine, 1974, Volume: 17, Issue:3 Topics: Adrenocorticotropic Hormone; Adult; Autoimmune Diseases; Azathioprine; Blood Platelets; Blood Transf	1974
[Ocular changes in Graves-Basedov disease]. Polskie Archiwum Medycyny Wewnetrznej, 1972, Volume: 49, Issue:5 Topics: Autoimmune Diseases; Eye Diseases; Eye Manifestations; Female; Graves Disease; Humans; Long-Acting T	1972
Polymyositis: new light on pathogenesis and treatment. Proceedings of the Australian Association of Neurologists, 1973, Volume: 9 Topics: Adult; Antilymphocyte Serum; Autoimmune Diseases; Dermatomyositis; Humans; Immunosuppressive Agents;	1973
Immunosuppressive therapy for chronic liver disease. Journal of the Royal College of Physicians of London, 1973, Volume: 8, Issue:1 Topics: Anti-Inflammatory Agents; Antibody Formation; Autoantibodies; Autoimmune Diseases; Azathioprine; Chr	1973
Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology, 1974, Volume: 66, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Antibodies; Autoimmune Diseases; Azathioprine; Child, Preschool; Chr	1974
Chronic hepatitis. Gut, 1974, Volume: 15, Issue:7 Topics: Adult; Animals; Autoimmune Diseases; Azathioprine; Chemical and Drug Induced Liver Injury; Child; Ch	1974
Autoimmune thrombocytopenic purpura. The American journal of the medical sciences, 1971, Volume: 261, Issue:3 Topics: Acute Disease; Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Blood Cell Count; Blood Plate	1971
Subacute thyroiditis. The American journal of medicine, 1971, Volume: 51, Issue:1 Topics: Aspirin; Autoimmune Diseases; Cortisone; Diagnosis, Differential; Female; Humans; Male; Myxedema; Pr	1971

Article	Year
Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial. Lupus science & medicine, 2020, Volume: 7, Issue:1 Topics: Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; B	2020
Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. International journal of rheumatic diseases, 2017, Volume: 20, Issue:5 Topics: Adult; Aged; Autoimmune Diseases; Biomarkers; China; Female; Glucocorticoids; Humans; Immunoglobulin	2017
Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2009, Volume: 30, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Aged; Autoimmune Diseases; Double-Blind Method; Ear, Inner; Female;	2009
Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection? European review for medical and pharmacological sciences, 2009, Volume: 13 Suppl 1 Topics: Aged; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Hepacivirus; H	2009
Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA, 2003, Oct-08, Volume: 290, Issue:14 Topics: Audiometry; Autoimmune Diseases; Double-Blind Method; Ear Diseases; Ear, Inner; Glucocorticoids; Hea	2003
Serial audiometry in a clinical trial of AIED treatment. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2005, Volume: 26, Issue:5 Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Audiometry, Speech; Auditory Threshold; Autoimmune D	2005
Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstetrics and gynecology, 2006, Volume: 107, Issue:1 Topics: Adult; Autoimmune Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administratio	2006
A trial of immunotherapy in aplastic anemia and pure red cell aplasia. Journal of clinical apheresis, 1983, Volume: 1, Issue:2 Topics: Adult; Anemia, Aplastic; Autoimmune Diseases; Clinical Trials as Topic; Cyclophosphamide; Female; He	1983
Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura. Lancet (London, England), 1995, Jul-22, Volume: 346, Issue:8969 Topics: Adult; Autoimmune Diseases; Blood Platelets; Chronic Disease; Female; Hematopoiesis; Heparin; Humans	1995
A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thrombosis and haemostasis, 1993, Nov-15, Volume: 70, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Factor VIII;	1993
Clinical, historic, and therapeutic features of cicatricial pemphigoid. A literature review and open therapeutic trial with corticosteroids. Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:4 Topics: Aged; Autoantibodies; Autoimmune Diseases; Basement Membrane; Clobetasol; Complement C3; Female; Hum	1993
Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses. Journal of hepatology, 1993, Volume: 17, Issue:2 Topics: Administration, Oral; Adult; Autoimmune Diseases; Azathioprine; Drug Administration Schedule; Drug T	1993
Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases. British journal of rheumatology, 1997, Volume: 36, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Arthrit	1997
Systemic corticosteroid therapy of oral vesiculoerosive diseases (OVED). An open trial. Minerva stomatologica, 1998, Volume: 47, Issue:10 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Autoimmune Diseases; Erythema Multiforme; Female;	1998
The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group. Transfusion science, 1998, Volume: 19, Issue:3 Topics: Acute Disease; Albumins; Autoantibodies; Autoimmune Diseases; Canada; Combined Modality Therapy; Fem	1998
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica, 2002, Volume: 87, Issue:2 Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D	2002
Steroid treatment of male subfertility caused by antisperm antibodies. Lancet (London, England), 1979, Sep-08, Volume: 2, Issue:8141 Topics: Autoantibodies; Autoimmune Diseases; Cell Count; Humans; Male; Methylprednisolone; Oligospermia; Pre	1979
Chronic active hepatitis: immunopathogenesis and immunotherapy. Israel journal of medical sciences, 1979, Volume: 15, Issue:3 Topics: Antibodies, Viral; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Carrier State; Chronic D	1979
The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia. An interim analysis. Blut, 1989, Volume: 59, Issue:1 Topics: Adult; Autoimmune Diseases; Humans; Immunization, Passive; Prednisone; Prospective Studies; Purpura,	1989
Cyclosporine trials in diabetes: updated results of the French experience. Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 4 Topics: Autoimmune Diseases; Azathioprine; C-Peptide; Clinical Trials as Topic; Cyclosporins; Diabetes Melli	1988
Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine, 1985, Volume: 64, Issue:4 Topics: Adolescent; Adult; Autoantibodies; Autoimmune Diseases; Basement Membrane; Clinical Trials as Topic;	1985
Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy. Zeitschrift fur Gastroenterologie, 1985, Volume: 23, Issue:5 Topics: Adult; Aged; Alkaline Phosphatase; Autoantibodies; Autoimmune Diseases; Clinical Trials as Topic; Cr	1985
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (London, England), 1972, Aug-12, Volume: 2, Issue:7772 Topics: Antibodies; Antigens; Autoimmune Diseases; Bilirubin; Blood Pressure; Cell Migration Inhibition; Chr	1972
Lymphocytes sensitised to basic encephalitogen in patients with multiple sclerosis unresponsive to steroid therapy. Lancet (London, England), 1974, Jul-13, Volume: 2, Issue:7872 Topics: Adrenocorticotropic Hormone; Autoantigens; Autoimmune Diseases; Brain; Cells, Cultured; Humans; Immu	1974
Glucocorticoids in liver diseases. Acta medica Scandinavica. Supplementum, 1969, Volume: 500 Topics: Acute Disease; Adult; Alcoholism; Autoimmune Diseases; Chronic Disease; Female; Glucocorticoids; Hep	1969

prednisone and Autoimmune Diseases